These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 2600328)
21. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. Müller U; Helbling A; Berchtold E J Allergy Clin Immunol; 1992 Feb; 89(2):529-35. PubMed ID: 1740583 [TBL] [Abstract][Full Text] [Related]
22. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious. Goldberg A; Confino-Cohen R J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of the basophil activation test in evaluating Hymenoptera venom sensitization. Peternelj A; Silar M; Bajrovic N; Adamic K; Music E; Kosnik M; Korosec P Wien Klin Wochenschr; 2009; 121(9-10):344-8. PubMed ID: 19562299 [TBL] [Abstract][Full Text] [Related]
24. Clinical features of children with venom allergy and risk factors for severe systemic reactions. Yavuz ST; Sahiner UM; Buyuktiryaki B; Soyer OU; Sackesen C; Sekerel BE; Tuncer A Int Arch Allergy Immunol; 2013; 160(3):313-21. PubMed ID: 23095437 [TBL] [Abstract][Full Text] [Related]
31. [Hyper-accelerated immunotherapy with Hymenoptera venoms]. Sabbah A; Bonneau JC; Drouet M; Le Sellin J Allerg Immunol (Paris); 1987 Apr; 19(4):156-8, 160, 162-3. PubMed ID: 3453132 [TBL] [Abstract][Full Text] [Related]
32. Evolution of sensitivity to Hymenoptera venom in 200 allergic patients followed for up to 3 years. Bousquet J; Knani J; Velasquez G; Menardo JL; Guilloux L; Michel FB J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):944-50. PubMed ID: 2600326 [TBL] [Abstract][Full Text] [Related]
33. The evaluation of the common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of an in-hospital insect sting. Blaauw PJ; Smithuis LO J Allergy Clin Immunol; 1985 May; 75(5):556-62. PubMed ID: 3989140 [TBL] [Abstract][Full Text] [Related]
34. Suitability of different glycoproteins and test systems for detecting cross-reactive carbohydrate determinant-specific IgE in hymenoptera venom-allergic patients. Mertens M; Brehler R Int Arch Allergy Immunol; 2011; 156(1):43-50. PubMed ID: 21447958 [TBL] [Abstract][Full Text] [Related]
35. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy. Sturm GJ; Heinemann A; Schuster C; Wiednig M; Groselj-Strele A; Sturm EM; Aberer W Allergy; 2007 Aug; 62(8):884-9. PubMed ID: 17620065 [TBL] [Abstract][Full Text] [Related]
36. Natural history of Hymenoptera venom allergy in Eastern Spain. Fernandez J; Soriano V; Mayorga L; Mayor M Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of Hymenoptera venom allergy and its immunological markers current in adults in Poland. Nittner-Marszalska M; Liebhart J; Liebhart E; Dor A; Dobek R; Obojski A; Medrala W Med Sci Monit; 2004 Jul; 10(7):CR324-9. PubMed ID: 15232507 [TBL] [Abstract][Full Text] [Related]
38. Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patients. Bernstein DI; Mittman RJ; Kagen SL; Korbee L; Enrione M; Bernstein IL J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):951-9. PubMed ID: 2480972 [TBL] [Abstract][Full Text] [Related]
39. Allergens in hymenoptera venom. VI. Cross reactivity of human IgE antibodies to the three vespid venoms and between vespid and paper wasp venoms. Hoffman DR Ann Allergy; 1981 Jun; 46(6):304-9. PubMed ID: 7247080 [TBL] [Abstract][Full Text] [Related]
40. Cellular in vitro assays in the diagnosis of Hymenoptera venom allergy. Scherer K; Weber JM; Jermann TM; Krautheim A; Tas E; Ueberschlag EV; Cammarata M; Bircher AJ Int Arch Allergy Immunol; 2008; 146(2):122-32. PubMed ID: 18204278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]